185.50p-2.00 (-1.07 %)15 Jan 2021, 12:53
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Oncimmune Holdings PLC Market & Company News

14.01.2021 09:49PDMR DealingRNS
06.01.2021 10:27Total Voting RightsRNS
18.12.2020 07:00PDMR DealingRNS
14.12.2020 07:00EarlyCDT Lung blood test launch into the NHSRNS
30.11.2020 11:21Results of Annual General MeetingRNS
11.11.2020 07:00Agreement with Augmenta BioworksRNS
09.11.2020 07:00Notice of AGM and Posting of Annual ReportRNS
30.10.2020 07:00Full year results and progress updateRNS
19.10.2020 07:21Replacement: Notice of Full Year ResultsRNS
19.10.2020 06:00Notice of Full Year Results ended 31 May 2020RNS
13.10.2020 06:00Agreement with Cedars-Sinai to Profile COVID-19RNS
08.10.2020 10:05Second Price Monitoring ExtnRNS
08.10.2020 10:00Price Monitoring ExtensionRNS
06.10.2020 06:00UK Government funding for tool for use in COVID-19RNS
23.09.2020 06:00Profiling samples from GenentechRNS
15.09.2020 13:00Block AdmissionRNS
11.09.2020 11:14New Incentivisation Scheme for Senior ManagementRNS
03.09.2020 06:00Cost-effectiveness study assessing EarlyCDT LungRNS
02.09.2020 06:00Autoantibody profiling agreement signedRNS
13.08.2020 10:38Exercise of Options and Total Voting RightsRNS
12.08.2020 06:00Appointment of Joint BrokersRNS
07.08.2020 06:00Exercise of Options and Total Voting RightsRNS
31.07.2020 06:00ERJ publishes results from the ECLS studyRNS
27.07.2020 06:00Roche Contract Expansion to Profile AutoantibodiesRNS
24.07.2020 13:52Exercise of Options and Total Voting RightsRNS
30.06.2020 06:00Exercise of OptionsRNS
09.06.2020 14:54Grant of Options and PDMR notificationRNS
08.06.2020 06:00Holdings in CompanyRNS
05.06.2020 13:00Price Monitoring ExtensionRNS
05.06.2020 08:02CORRECTION: Director/PDMR's DealingRNS
05.06.2020 06:00Director/PDMR's DealingRNS
04.06.2020 06:00Trading Update for 12 months to 31 May 2020RNS
02.06.2020 15:09Holding(s) in CompanyRNS
29.05.2020 13:40Holding(s) in CompanyRNS
29.05.2020 06:00Notice of Trading UpdateRNS
28.05.2020 10:06Second Price Monitoring ExtnRNS
28.05.2020 10:00Price Monitoring ExtensionRNS
28.05.2020 06:00Contract with Roche to Profile AutoantibodiesRNS
12.05.2020 06:00Drug Development Collaboration Agreement SignedRNS
06.05.2020 07:56PDMR DealingRNS
04.05.2020 16:08Directorate ChangeRNS
01.05.2020 09:32Grant of Options and PDMR notificationRNS
24.04.2020 14:59Director/PDMR ShareholdingRNS
07.04.2020 10:41PDMR DealingRNS
01.04.2020 09:31PDMR DealingRNS
25.03.2020 12:42PDMR DealingRNS
20.03.2020 14:09Holding(s) in CompanyRNS
18.03.2020 17:42Holding(s) in CompanyRNS
18.03.2020 12:19PDMR DealingRNS
17.03.2020 10:24NICE concludes review of EarlyCDT LungRNS
13.03.2020 11:42Issue of EquityRNS
12.03.2020 18:31PDMR / PCA DealingsRNS
04.03.2020 07:00US Commercial LaunchRNS
02.03.2020 15:35Director/PDMR's DealingRNS
18.02.2020 11:06Second Price Monitoring ExtnRNS
18.02.2020 11:00Price Monitoring ExtensionRNS
14.02.2020 16:41Second Price Monitoring ExtnRNS
14.02.2020 16:35Price Monitoring ExtensionRNS
14.02.2020 11:55Holding(s) in CompanyRNS
14.02.2020 11:05Second Price Monitoring ExtnRNS
14.02.2020 11:00Price Monitoring ExtensionRNS
12.02.2020 07:00Half Year ReportRNS
28.01.2020 07:00Lung Test More Cost Effective Compared to CTRNS
27.01.2020 07:00Notice of Capital Markets UpdateRNS
07.01.2020 07:00Notice of Half Year ResultsRNS
07.01.2020 07:00Change of Registered AddressRNS
29.11.2019 09:58Results of Annual General MeetingRNS
04.11.2019 14:46Notice of AGM and Posting of Annual ReportRNS
04.11.2019 07:00Draw down of second tranche of credit facilityRNS
01.11.2019 07:10Oncimmune and Biodesix seal dealRNS
31.10.2019 07:00Final ResultsRNS
25.10.2019 06:00Notice of Full Year Results ended May 2019RNS
20.09.2019 13:32Appointment of Joint BrokerRNS
20.09.2019 06:00EUR8.5m Credit Facility SecuredRNS
04.07.2019 09:38Commercialisation Partnership in RussiaRNS
28.06.2019 06:00Commercialisation Agreement in US with BiodesixRNS
26.06.2019 06:00Business UpdateRNS
04.06.2019 06:00Positive Results for Early Cancer Detection TestRNS
15.05.2019 06:00Regulatory Approval in Israel for EarlyCDT®-LungRNS
10.05.2019 06:00Initiation of a Multi-Centre Trial in ChinaRNS
17.04.2019 06:00Holding(s) in CompanyRNS
05.04.2019 06:00Agreement for Portugal and SpainRNS
02.04.2019 06:00Appointment of Parag Mallick to Scientific BoardRNS
01.04.2019 16:19Holding(s) in CompanyRNS
25.03.2019 07:00Spanish Private Hospital to Sell EarlyCDT®-LungRNS
19.03.2019 07:00Oncimmune acquires Protagen Diagnostics AGRNS
13.02.2019 07:00Half Year ResultsRNS
31.01.2019 07:00Notice of Half Year ResultsRNS
24.01.2019 07:00Grant of Options and PDMR notificationRNS
13.12.2018 07:00Oncimmune appoints new Scientific BoardRNS
06.12.2018 16:34Senior Leadership Team Appointments & Board ChangeRNS
30.11.2018 10:46Result of AGMRNS
28.11.2018 07:10Distribution Agreements & Registration Outside EURNS
05.11.2018 07:00Annual Report and Accounts and AGM NotificationRNS
31.10.2018 07:00Results for the year ended 31 May 2018RNS
01.10.2018 06:00Business UpdateRNS
28.09.2018 06:00Appointment of Non-Executive DirectorRNS
25.09.2018 06:00Grant of optionsRNS
24.09.2018 06:00Board ChangeRNS
26.07.2018 11:33Notification & Public Disclosure of a TransactionRNS
Showing 1 to 100 of 1,000